Delivered 9th consecutive year of
record-high net sales and Adjusted EBITDA
Full year Adjusted EPS of €1.78
Increases full year 2025 Adjusted EPS guidance
to €1.85-€1.89
WOKING, England, March 3,
2025 /PRNewswire/ -- Nomad Foods Limited
(NYSE: NOMD) (the "Company" or "Nomad Foods"), today reported
financial results for the three and twelve-month periods ended
December 31, 2024.
Nomad Foods delivered strong results in fiscal year 2024, with
accelerated organic sales growth driven by higher volumes, while
also achieving robust margin expansion and market share gains. The
Company maintained its commitment to shareholder returns,
distributing €208 million throughout the year in the form of
dividends and shares repurchases. Looking ahead to fiscal year
2025, management expects to maintain this momentum with continued
top and bottom-line growth. As previously announced, the Board of
Directors approved a 13% increase to the company's 1Q25 cash
dividend, reflecting continued confidence in the Company's strong
cash generation and growth prospects.
Key operating highlights and financial performance for the
fourth quarter 2024, when compared to the fourth quarter 2023,
include:
- Reported revenue increased 4.3% to €793 million
- Organic revenue growth of 3.1% with volume growth of
4.7%
- Adjusted EBITDA up 17.6% to €137 million
- Adjusted EPS rose 31% to €0.42
Key operating highlights and financial performance for the full
year 2024, when compared to the full year 2023, include:
- Reported revenue increased 1.8% to €3.1 billion
- Organic revenue growth of 1.0% with volume growth of
1.3%
- Adjusted EBITDA increased 5.6% to €565 million
- Adjusted EPS rose 11% to €1.78
- Adjusted free cash flow of €292 million, representing an
adjusted free cash flow conversation of 101%
2025 full year guidance
For the full year 2025,
Nomad Foods continues to expect organic revenue growth of 1%-3% and
Adjusted EBITDA growth of 2%-4% while meaningfully increasing
investment in its products and brands again in 2025. Adjusted EPS
is now expected to be €1.85-€1.89, implying growth of 4-6%, versus
the prior outlook of €1.81-€1.85. Based on USD/EUR exchange rate as
of February 25, 2025, this translates
into 2025 Adjusted EPS of $1.94-$1.98. The
Company also continues to expect full year adjusted free cash flow
conversion of 90% or greater.
Management & Board Comments
Stéfan Descheemaeker, Nomad Foods' Chief Executive Officer,
stated, "Our 2024 results demonstrate the impact of our focused
brand investments and operational excellence, marking our ninth
consecutive year of sales and Adjusted EBITDA growth. The
investments we began to make in 2023 took hold and delivered strong
returns in 2024, as evidenced by our accelerating volume momentum
through the final three quarters and market share gains in each of
the last two quarters of the year. Growth can be choppy
month-to-month and quarter-to-quarter but the underlying trendline
of improvement is evident in our results. We significantly
strengthened our innovation engine, increasing our innovation as a
percent of sales year-over-year, while executing more impactful
merchandising programs that resonated with consumers at
point-of-sale. Importantly, we accomplished this while expanding
margins through a combination of supply chain productivity
initiatives and focused growth investments that yielded healthy mix
gains. The strength of our execution this year reflects the
dedication of our teams and the power of our brands. As we enter
2025, we're confident in our proven strategy and capabilities to
deliver what would be our 10th consecutive year of sales
and Adjusted EBITDA growth."
Noam Gottesman, Nomad Foods'
Co-Chairman and Founder, commented, "As we enter our tenth year as
a public company, I have never been more optimistic about the
growth potential of Nomad Foods. Over the past nine years we have
curated a portfolio of iconic brands in an attractive category
while building a high-performing team of top-tier talent. Nomad
Foods has become a growth advantaged food company as evidenced by
its widening top and bottom-line outperformance versus industry
peers. We expect this outperformance to continue."
Fourth Quarter of 2024 results compared to the Fourth
Quarter of 2023
- Revenue increased 4.3% to €793 million. Organic
revenue increase of 3.1% was driven by a 1.6% price/mix decline
offset by 4.7% volume growth.
- Gross profit increased 9% to €226 million. Gross margin
increased 120 basis points to 28.5% due to a positive product mix
performance as we invested behind our core most profitable Must Win
Battles, and improved supply chain productivity.
- Adjusted operating expenses decreased 3% to €114 million
due to lower A&P as we cycled a sharp increase in 4Q23 and
benefited from a more even investment cadence through 2024.
- Adjusted EBITDA increased by 17.6% to €137 million
and Adjusted Profit after tax increased 28% to €67
million.
- Adjusted EPS increased 31% to €0.42, reflecting the
increase in Adjusted Profit after tax and fewer shares outstanding.
Reported Diluted EPS increased 113% to €0.32.
Year Ended 2024 results compared to the Year Ended
2023
- Revenue increased 1.8% to €3.1 billion. Organic
revenue increase of 1.0% was driven by a 0.3% decline in
price/mix offset by a 1.3% increase in volume.
- Gross profit increased 7% to €918 million. Gross margin
increased 140 basis points to 29.6% due to a positive product mix
performance as we invested behind our core most profitable Must Win
Battles, and improved supply chain productivity.
- Adjusted operating expenses increased 7% to €450 million
due to increased A&P, and ongoing investments in capabilities
development with some inflationary headwinds.
- Adjusted EBITDA increased 5.6% to €565 million and
Adjusted Profit after tax increased 5% to €289
million,.
- Adjusted EPS increased 11% to €1.78, reflecting the
increase in Adjusted Profit after tax and fewer shares outstanding.
Reported Diluted EPS increased 24% to €1.40.
- The company returned €208 million to shareholders in
2024 in the form of dividends and share repurchase activity. The
basic shares outstanding at year-end were 156.1 million; a 4%
decrease from year-end 2023.
Conference Call and Webcast
The Company will host a conference call with members of the
executive management team to discuss these results today, Monday,
March 3, 2025 at 1:30 p.m. GMT
(8:30 a.m. Eastern Standard Time).
To participate on the live call listeners in North America may dial +1-833-816-1430 and
international listeners may dial +1-412-317-0522. Additionally,
there will be a presentation to accompany the conference call and
the call is being webcast. Both can be accessed at the Nomad
Foods website at www.nomadfoods.com under Investor Relations. A
replay of the conference call will be available on the Company
website for two weeks following the event and can be accessed by
listeners in North America by
dialing +1-844-512-2921 and by international listeners by dialing
+1-412-317-6671; the replay pin number is 10196693.
Investor Relations Contact
Jason English
investorrelations@nomadfoods.com
Media Contact
Elaine
McCrimmon, Group Corporate Affairs Director
elaine.mccrimmon@nomadfoods.com
About Nomad Foods
Nomad Foods (NYSE: NOMD) is Europe's leading frozen food company. The
Company's portfolio of iconic brands, which includes Birds
Eye, Findus, iglo, Ledo and Frikom,
have been a part of consumers' meals for generations, standing for
great tasting food that is convenient, high quality and nutritious.
Nomad Foods is headquartered in the United Kingdom. Additional information may be
found at www.nomadfoods.com.
Non-IFRS Financial Information
Nomad Foods is presenting Adjusted and Organic financial
information, which is considered non-IFRS financial information,
for the three and twelve months ended December 31, 2024 and
for comparative purposes, the three and twelve months ended
December 31, 2023.
Adjusted financial information for the three and twelve months
ended December 31, 2024 and 2023 presented in this press
release reflects the historical reported financial statements of
Nomad Foods, adjusted primarily for share based payment expenses
and related employer payroll taxes, non-operating M&A related
costs, acquisition purchase price adjustments, exceptional items
and foreign currency exchange charges/gains.
Adjusted EBITDA is profit or loss for the period before
taxation, net financing costs, depreciation and amortization,
adjusted to exclude, when they occur, the impacts of exited
markets, acquisition purchase price adjustments and exceptional
items such as restructuring charges, goodwill and intangible asset
impairment charges and other unusual or non-recurring items. In
addition, we exclude other adjustments such as the impact of share
based payment expenses and related employer payroll taxes, and
non-operating M&A related costs, because we do not believe they
are indicative of our normal operating costs, can vary
significantly in amount and frequency, and are unrelated to our
underlying operating performance. The Company believes Adjusted
EBITDA provides important comparability of underlying operating
results, allowing investors and management to assess operating
performance on a consistent basis.
Adjusted EBITDA should not be considered as an alternative to
profit/(loss) for the period, determined in accordance with IFRS,
as an indicator of the Company's operating performance.
Adjusted Profit for the period is defined as profit for the
period excluding, when they occur, the impacts of exited markets,
acquisition purchase price adjustments and exceptional items such
as restructuring charges, goodwill and intangible asset impairment
charges, unissued preferred share dividends, as well as certain
other items considered unusual or non-recurring in nature. In
addition, we exclude other adjustments such as the impact of share
based payment expenses and related employer payroll taxes, and
non-operating M&A related costs, because we do not believe they
are indicative of our normal operating costs, can vary
significantly in amount and frequency, and are unrelated to our
underlying operating performance. The Company believes Adjusted
Profit after tax provides important comparability of underlying
operating results, allowing investors and management to assess
operating performance on a consistent basis.
Adjusted EPS is defined as diluted earnings per share excluding,
when they occur, the impacts of exited markets, acquisition
purchase price adjustments and exceptional items such as
restructuring charges, goodwill and intangible asset impairment
charges, as well as certain other items considered unusual or
non-recurring in nature. In addition, we exclude other adjustments
such as the impact of share based payment expenses and related
employer payroll taxes, and non-operating M&A related costs,
because we do not believe they are indicative of our normal
operating costs, can vary significantly in amount and frequency,
and are unrelated to our underlying operating performance. The
Company believes Adjusted EPS provides important comparability of
underlying operating results, allowing investors and management to
assess operating performance on a consistent basis.
Organic revenue growth/(decline) is an adjusted measurement of
our operating results. The comparison for the three and twelve
months ended December 31, 2024 and 2023 presented in this
press release takes into consideration only those activities that
were in effect during both time periods. Organic revenue
growth/(decline) reflects reported revenue adjusted for currency
translation and non-comparable trading items such as expansion,
acquisitions, disposals, closures, trading day impacts or any other
event that artificially impacts the comparability of our results
period over period.
Adjustments for currency translation are calculated by
translating data of the current and comparative periods using a
budget foreign exchange rate that is set once a year as part of the
Company's internal annual forecast process.
Adjusted Free Cash Flow – Adjusted free cash flow is the amount
of cash generated from operating activities before cash flows
related to exceptional items (as described above), non-operating
M&A related costs and working capital movements on employer
taxes associated with share based payment awards, but after capital
expenditure (on property, plant and equipment and intangible
assets), net interest paid, proceeds/(payments) on settlement of
derivatives where hedge accounting is not applied and payments of
lease liabilities. Adjusted free cash flow reflects cash flows that
could be used for payment of dividends, repayment of debt or to
fund acquisitions or other strategic objectives.
Cash flow conversion is Adjusted Free Cash Flow as percentage of
Adjusted Profit for the period.
Adjusted and Organic non-IFRS financial information should be
read in conjunction with the unaudited financial statements of
Nomad Foods included in this press release as well as the
historical financial statements of the Company previously filed
with the SEC.
Nomad Foods believe its non-IFRS financial measures provide an
important additional measure with which to monitor and evaluate the
Company's ongoing financial results, as well as to reflect its
acquisitions. Nomad Foods' calculation of these financial measures
may be different from the calculations used by other companies and
comparability may therefore be limited. The Adjusted and Organic
financial information presented herein is based upon certain
assumptions that Nomad Foods believes to be reasonable and is
presented for informational purposes only and is not necessarily
indicative of any anticipated financial position or future results
of operations that the Company will experience. You should not
consider the Company's non-IFRS financial measures an alternative
or substitute for the Company's reported results and are cautioned
not to place undue reliance on these results and information as
they may not be representative of our actual or future results as a
Company.
Please see on pages 9 to 18, the non-IFRS reconciliation tables
attached hereto and the schedules accompanying this release for an
explanation and reconciliation of the Adjusted and Organic
financial information to the most directly comparable IFRS measure.
The Company is unable to reconcile, without unreasonable efforts,
Adjusted EPS guidance to the most directly comparable IFRS
measure.
Nomad Foods Limited
As Reported
Statements of Profit
or Loss (unaudited)
Three months ended
December 31, 2024 and December 31, 2023
|
|
€ in
millions
|
Three months
ended
December 31, 2024
|
|
Three months
ended
December 31, 2023
|
Revenue
|
793.4
|
|
760.8
|
Cost of
sales
|
(567.5)
|
|
(553.1)
|
Gross
profit
|
225.9
|
|
207.7
|
Other operating
expenses
|
(115.1)
|
|
(122.6)
|
Exceptional
items
|
(19.3)
|
|
(18.4)
|
Operating
profit
|
91.5
|
|
66.7
|
Finance
income
|
4.4
|
|
6.2
|
Finance
costs
|
(34.6)
|
|
(26.7)
|
Net financing
costs
|
(30.2)
|
|
(20.5)
|
Profit before
tax
|
61.3
|
|
46.2
|
Taxation
|
(9.9)
|
|
(21.5)
|
Profit for the
period
|
51.4
|
|
24.7
|
|
|
|
|
Basic earnings per
share
|
|
|
|
Weighted average shares
outstanding in millions
|
158.5
|
|
163.8
|
Basic earnings per
share in €
|
0.32
|
|
0.15
|
Diluted earnings per
share
|
|
|
|
Weighted average shares
outstanding in millions
|
159.2
|
|
164.4
|
Diluted earnings per
share in €
|
0.32
|
|
0.15
|
Statements of Profit
or Loss (audited)
Twelve months ended
December 31, 2024 and December 31, 2023
|
|
€ in
millions
|
Twelve months
ended December 31,
2024
|
|
Twelve months
ended December 31,
2023
|
Revenue
|
3,099.8
|
|
3,044.5
|
Cost of
sales
|
(2,182.0)
|
|
(2,185.8)
|
Gross
profit
|
917.8
|
|
858.7
|
Other operating
expenses
|
(461.3)
|
|
(445.8)
|
Exceptional
items
|
(69.5)
|
|
(72.5)
|
Operating
profit
|
387.0
|
|
340.4
|
Finance
income
|
30.1
|
|
22.8
|
Finance
costs
|
(139.2)
|
|
(109.6)
|
Net financing
costs
|
(109.1)
|
|
(86.8)
|
Profit before
tax
|
277.9
|
|
253.6
|
Taxation
|
(50.8)
|
|
(60.9)
|
Profit for the
period
|
227.1
|
|
192.7
|
|
|
|
|
Basic
earnings per share
|
|
|
|
Weighted average shares
outstanding in millions
|
161.5
|
|
170.6
|
Basic earnings per
share in €
|
1.41
|
|
1.13
|
Diluted earnings per
share
|
|
|
|
Weighted average shares
outstanding in millions
|
162.2
|
|
171.2
|
Diluted
earnings per share in €
|
1.40
|
|
1.13
|
Nomad Foods Limited
As Reported
Statements of
Financial Position (audited)
As at December 31,
2024 and December 31, 2023
|
|
€ in
millions
|
As at December 31,
2024
|
|
As at December 31,
2023
|
Non-current
assets
|
|
|
|
Goodwill
|
2,106.1
|
|
2,105.0
|
Intangible
assets
|
2,472.9
|
|
2,468.2
|
Property, plant and
equipment
|
591.1
|
|
563.7
|
Other non-current
assets
|
8.6
|
|
7.1
|
Derivative financial
instruments
|
4.3
|
|
0.7
|
Deferred tax
assets
|
14.7
|
|
106.9
|
Total non-current
assets
|
5,197.7
|
|
5,251.6
|
Current
assets
|
|
|
|
Cash and cash
equivalents
|
403.3
|
|
412.9
|
Inventories
|
441.5
|
|
446.4
|
Trade and other
receivables
|
334.1
|
|
263.4
|
Current tax
receivable
|
37.6
|
|
40.7
|
Indemnification
assets
|
0.5
|
|
0.5
|
Derivative financial
instruments
|
16.9
|
|
1.2
|
Total current
assets
|
1,233.9
|
|
1,165.1
|
Total
assets
|
6,431.6
|
|
6,416.7
|
Current
liabilities
|
|
|
|
Trade and other
payables
|
829.1
|
|
769.8
|
Current tax
payable
|
226.7
|
|
189.5
|
Provisions
|
27.1
|
|
35.1
|
Loans and
borrowings
|
26.0
|
|
21.4
|
Derivative financial
instruments
|
14.4
|
|
12.2
|
Total current
liabilities
|
1,123.3
|
|
1,028.0
|
Non-current
liabilities
|
|
|
|
Loans and
borrowings
|
2,151.4
|
|
2,113.7
|
Employee
benefits
|
152.1
|
|
158.3
|
Other non-current
liabilities
|
0.5
|
|
0.5
|
Provisions
|
2.7
|
|
1.4
|
Derivative financial
instruments
|
46.4
|
|
97.8
|
Deferred tax
liabilities
|
292.7
|
|
425.1
|
Total non-current
liabilities
|
2,645.8
|
|
2,796.8
|
Total
liabilities
|
3,769.1
|
|
3,824.8
|
Net
assets
|
2,662.5
|
|
2,591.9
|
Equity attributable
to equity holders
|
|
|
|
Share capital and
capital reserve
|
1,316.4
|
|
1,426.1
|
Share based
compensation reserve
|
26.2
|
|
31.4
|
Translation
reserve
|
135.3
|
|
101.0
|
Other
reserves
|
(14.9)
|
|
(24.6)
|
Retained
earnings
|
1,199.5
|
|
1,058.0
|
Total
equity
|
2,662.5
|
|
2,591.9
|
Nomad Foods Limited
As Reported
Statements of Cash
Flows (audited)
For the twelve
months ended December 31, 2024 and the twelve months ended December
31, 2023
|
|
€ in
millions
|
Twelve months
ended
December 31, 2024
|
|
Twelve months
ended
December 31, 2023
|
Cash flows from
operating activities
|
|
|
|
Profit for the
period
|
227.1
|
|
192.7
|
Adjustments
for:
|
|
|
|
Exceptional
items
|
69.5
|
|
72.5
|
Share based payment
expense
|
8.8
|
|
24.1
|
Depreciation and
amortization
|
96.9
|
|
95.0
|
Loss on disposal and
impairment of property, plant and equipment
|
1.6
|
|
1.2
|
Net finance
costs
|
109.1
|
|
86.8
|
Taxation
|
50.8
|
|
60.9
|
Operating cash flow
before changes in working capital, provisions and
exceptional items
|
563.8
|
|
533.2
|
(Increase)/decrease in
inventories
|
(1.2)
|
|
18.8
|
(Increase)/decrease in
trade and other receivables
|
(75.0)
|
|
0.3
|
Increase in trade and
other payables
|
68.6
|
|
42.1
|
Decrease in employee
benefits and other provisions
|
(4.0)
|
|
(3.2)
|
Cash generated from
operations before tax and exceptional items
|
552.2
|
|
591.2
|
Payments relating to
exceptional items
|
(72.1)
|
|
(67.6)
|
Receipts relating to
exceptional items
|
4.4
|
|
—
|
Tax paid
|
(49.1)
|
|
(92.8)
|
Net cash flows from
operating activities
|
435.4
|
|
430.8
|
Cash flows from
investing activities
|
|
|
|
Purchase of property,
plant and equipment and intangibles
|
(80.3)
|
|
(82.4)
|
Interest
received
|
10.2
|
|
5.3
|
Redemption of
investments
|
5.7
|
|
0.3
|
Cash used in
investing activities
|
(64.4)
|
|
(76.8)
|
Cash flows from
financing activities
|
|
|
|
Repurchase of ordinary
shares
|
(118.7)
|
|
(170.9)
|
Dividends
paid
|
(89.2)
|
|
—
|
Payments related to
shares withheld for tax
|
(5.8)
|
|
(7.1)
|
Issuance of new loans
and notes
|
—
|
|
6.0
|
Repayment of loan
principal
|
(6.5)
|
|
(12.6)
|
Payment of lease
liabilities
|
(31.3)
|
|
(30.1)
|
Payment of financing
fees
|
(2.7)
|
|
(3.3)
|
Interest
paid
|
(112.2)
|
|
(93.9)
|
Payment of interest on
tax relating to legacy tax audits
|
—
|
|
(9.2)
|
Payments on settlement
of derivatives
|
—
|
|
(0.4)
|
Net cash used in
financing activities
|
(366.4)
|
|
(321.5)
|
Net increase in cash
and cash equivalents
|
4.6
|
|
32.5
|
Cash and cash
equivalents at beginning of period
|
399.7
|
|
366.8
|
Effect of exchange
rate fluctuations
|
(1.0)
|
|
0.4
|
Cash and cash
equivalents at end of period(1)
|
403.3
|
|
399.7
|
|
|
(1)
|
Cash and cash
equivalents includes bank overdrafts of nil for the twelve months
ended December 31, 2024 ended December 31, 2024 (2023: €13.2
million).
|
Nomad Foods Limited
Reconciliation of Non-IFRS
Financial Measures
(In € millions, except per share
data)
The following table reconciles adjusted financial information
for the three months ended December 31,
2024 to the reported results of Nomad Foods for such
period.
Adjusted Statement
of Profit or Loss (unaudited)
Three months ended December 31, 2024
|
|
€ in
millions, except per share data
|
As reported for
the
three months ended
December 31, 2024
|
|
Adjustments
|
|
|
|
As adjusted for
the
three months ended
December 31, 2024
|
Revenue
|
793.4
|
|
—
|
|
|
|
793.4
|
Cost of
sales
|
(567.5)
|
|
—
|
|
|
|
(567.5)
|
Gross
profit
|
225.9
|
|
—
|
|
|
|
225.9
|
Other operating
expenses
|
(115.1)
|
|
0.8
|
|
(a)
|
|
(114.3)
|
Exceptional
items
|
(19.3)
|
|
19.3
|
|
(b)
|
|
—
|
Operating
profit
|
91.5
|
|
20.1
|
|
|
|
111.6
|
Finance
income
|
4.4
|
|
—
|
|
|
|
4.4
|
Finance
costs
|
(34.6)
|
|
3.2
|
|
|
|
(31.4)
|
Net financing
costs
|
(30.2)
|
|
3.2
|
|
(c)
|
|
(27.0)
|
Profit before
tax
|
61.3
|
|
23.3
|
|
|
|
84.6
|
Taxation
|
(9.9)
|
|
(7.6)
|
|
(d)
|
|
(17.5)
|
Profit for the
period
|
51.4
|
|
15.7
|
|
|
|
67.1
|
|
|
|
|
|
|
|
|
Weighted average shares
outstanding in millions - basic
|
158.5
|
|
—
|
|
|
|
158.5
|
Basic earnings per
share in €
|
0.32
|
|
|
|
|
|
0.42
|
Weighted average shares
outstanding in millions - diluted
|
159.2
|
|
—
|
|
|
|
159.2
|
Diluted earnings per
share in €
|
0.32
|
|
|
|
|
|
0.42
|
|
|
(a)
|
Share based payment
charge including employer payroll taxes of €0.4 million and a
non-operating M&A related costs of €0.4 million.
|
(b)
|
Exceptional items which
management believes will only recur over a limited number of
financial periods based in most cases on the completion of the
particular project or program, and do not have a continuing impact.
See table 'Adjusted EBITDA (unaudited) three months ended December
31, 2024' on the next page for a detailed list of exceptional
items.
|
(c)
|
Elimination of €3.2
million of foreign exchange translation losses.
|
(d)
|
Tax impact of the above
at the applicable tax rate for each adjustment, determined by the
nature of the item and the jurisdiction in which it
arises.
|
Nomad Foods Limited
Reconciliation of Non-IFRS
Financial Measures (continued)
The following table reconciles Adjusted EBITDA for the three
months ended December 31, 2024 to the reported results of
Nomad Foods for such period.
Adjusted EBITDA
(unaudited)
Three months ended
December 31, 2024
|
|
€ in
millions
|
For the three
months
ended December 31,
2024
|
|
|
Profit for the
period
|
51.4
|
|
|
Taxation
|
9.9
|
|
|
Net financing
costs
|
30.2
|
|
|
Depreciation and
amortization
|
25.5
|
|
|
Exceptional
items:
|
|
|
|
Business
Transformation Program
|
20.8
|
|
(a)
|
Settlement of
legacy matters
|
(1.5)
|
|
(b)
|
Other
Adjustments:
|
|
|
|
Other
add-backs
|
0.8
|
|
(c)
|
Adjusted EBITDA
(d)
|
137.1
|
|
|
|
|
(a)
|
Expenses associated
with the multi-year, enterprise-wide transformation and
optimization program. Expenses in the period consist of
restructuring, severance and transformational project costs,
including business technology transformation initiative costs and
related professional fees.
|
(b)
|
Income and expenses
associated with the release of acquired provisions relating to
periods prior to acquisition by the Company and other gains or
charges associated with items that were originally recognized as
exceptional.
|
(c)
|
Represents the
elimination of share based payment charge including employer
payroll taxes of €0.4 million and elimination of a non-operating
M&A related costs of €0.4 million.
|
(d)
|
Adjusted EBITDA margin
of 17.3% for the three months ended December 31, 2024 is calculated
by dividing Adjusted EBITDA by Revenue of €793.4
million.
|
Nomad Foods Limited
Reconciliation of Non-IFRS
Financial Measures (continued)
The following table reconciles Adjusted financial information
for the three months ended December 31,
2023 to the reported results of Nomad Foods for such
period.
Adjusted Statements
of Profit or Loss (unaudited)
Three months ended
December 31, 2023
|
|
€ in
millions, except per share data
|
As reported for the
three months
ended December 31,
2023
|
|
Adjustments
|
|
|
|
As adjusted for
the
three months ended
December 31, 2023
|
Revenue
|
760.8
|
|
—
|
|
|
|
760.8
|
Cost of
sales
|
(553.1)
|
|
—
|
|
|
|
(553.1)
|
Gross
profit
|
207.7
|
|
—
|
|
|
|
207.7
|
Other operating
expenses
|
(122.6)
|
|
5.3
|
|
(a)
|
|
(117.3)
|
Exceptional
items
|
(18.4)
|
|
18.4
|
|
(b)
|
|
—
|
Operating
profit
|
66.7
|
|
23.7
|
|
|
|
90.4
|
Finance
income
|
6.2
|
|
(5.2)
|
|
|
|
1.0
|
Finance
costs
|
(26.7)
|
|
0.4
|
|
|
|
(26.3)
|
Net financing
costs
|
(20.5)
|
|
(4.8)
|
|
(c)
|
|
(25.3)
|
Profit before
tax
|
46.2
|
|
18.9
|
|
|
|
65.1
|
Taxation
|
(21.5)
|
|
8.7
|
|
(d)
|
|
(12.8)
|
Profit for the
period
|
24.7
|
|
27.6
|
|
|
|
52.3
|
|
|
|
|
|
|
|
|
Weighted average shares
outstanding in millions - basic
|
163.8
|
|
—
|
|
|
|
163.8
|
Basic earnings per
share in €
|
0.15
|
|
|
|
|
|
0.32
|
Weighted average shares
outstanding in millions - diluted
|
164.4
|
|
—
|
|
|
|
164.4
|
Diluted earnings per
share in €
|
0.15
|
|
|
|
|
|
0.32
|
|
|
(a)
|
Share based payment
charge including employer payroll taxes of €5.1 million and a
non-operating M&A related costs of €0.2 million.
|
(b)
|
Exceptional items which
management believes will only recur over a limited number of
financial periods based in most cases on the completion of the
particular project or program, and do not have a continuing impact.
See table 'Adjusted EBITDA (unaudited) three months ended December
31, 2023' on the next page for a detailed list of exceptional
items.
|
(c)
|
Elimination of €4.9
million of foreign exchange translation gains, €0.3 million of
interest income on legacy tax audits and €0.4 million of charges
relating to the repricing of debt.
|
(d)
|
Tax impact of the above
at the applicable tax rate for each adjustment, determined by the
nature of the item and the jurisdiction in which it
arises.
|
Nomad Foods Limited
Reconciliation of Non-IFRS
Financial Measures (continued)
The following table reconciles Adjusted EBITDA for the three
months ended December 31, 2023 to the
reported results of Nomad Foods for such period.
Adjusted EBITDA
(unaudited)
Three months ended
December 31, 2023
|
|
€ in
millions
|
For the three
months
ended December 31,
2023
|
|
|
Profit for the
period
|
24.7
|
|
|
Taxation
|
21.5
|
|
|
Net financing
costs
|
20.5
|
|
|
Depreciation and
amortization
|
26.2
|
|
|
Exceptional
items:
|
|
|
|
Business
Transformation Program
|
16.6
|
|
(a)
|
Fortenova
Group integration costs
|
2.8
|
|
(b)
|
Settlement of
legacy matters
|
(1.0)
|
|
(c)
|
Other
Adjustments:
|
|
|
|
Other
add-backs
|
5.3
|
|
(d)
|
Adjusted EBITDA
(e)
|
116.6
|
|
|
|
|
(a)
|
Expenses associated
with the multi-year, enterprise-wide transformation and
optimization program. Expenses in the period consist of
restructuring, severance and transformational project costs,
including business technology transformation initiative costs and
related professional fees.
|
(b)
|
Expenses associated
with the integration of the Fortenova Group acquired on
September 30, 2021.
|
(c)
|
Income and expenses
associated with the release of acquired provisions relating to
periods prior to acquisition by the Company and other gains or
charges associated with items that were originally recognized as
exceptional.
|
(d)
|
Represents the
elimination of share based payment charge including employer
payroll taxes of €5.1 million and elimination of a non-operating
M&A related costs of €0.2 million.
|
(e)
|
Adjusted EBITDA margin
of 15.3% for the three months ended December 31, 2023 is calculated
by dividing Adjusted EBITDA by Revenue of €760.8
million.
|
Nomad Foods Limited
Reconciliation of Non-IFRS
Financial Measures (continued)
The following table reconciles adjusted financial information
for the twelve months ended December 31, 2024 to the reported
results of Nomad Foods for such period.
Adjusted Statement
of Profit or Loss (unaudited)
Twelve months ended
December 31, 2024
|
|
€ in
millions, except per share data
|
As reported for
the
twelve months
ended December 31,
2024
|
|
Adjustments
|
|
|
|
As adjusted for
the
twelve months
ended December 31,
2024
|
Revenue
|
3,099.8
|
|
—
|
|
|
|
3,099.8
|
Cost of
sales
|
(2,182.0)
|
|
—
|
|
|
|
(2,182.0)
|
Gross
profit
|
917.8
|
|
—
|
|
|
|
917.8
|
Other operating
expenses
|
(461.3)
|
|
11.7
|
|
(a)
|
|
(449.6)
|
Exceptional
items
|
(69.5)
|
|
69.5
|
|
(b)
|
|
—
|
Operating
profit
|
387.0
|
|
81.2
|
|
|
|
468.2
|
Finance
income
|
30.1
|
|
(20.1)
|
|
|
|
10.0
|
Finance
costs
|
(139.2)
|
|
21.0
|
|
|
|
(118.2)
|
Net financing
costs
|
(109.1)
|
|
0.9
|
|
(c)
|
|
(108.2)
|
Profit before
tax
|
277.9
|
|
82.1
|
|
|
|
360.0
|
Taxation
|
(50.8)
|
|
(20.4)
|
|
(d)
|
|
(71.2)
|
Profit for the
period
|
227.1
|
|
61.7
|
|
|
|
288.8
|
|
|
|
|
|
|
|
|
Weighted average shares
outstanding in millions - basic
|
161.5
|
|
—
|
|
|
|
161.5
|
Basic earnings per
share in €
|
1.41
|
|
|
|
|
|
1.79
|
Weighted average shares
outstanding in millions - diluted
|
162.2
|
|
—
|
|
|
|
162.2
|
Diluted earnings per
share in €
|
1.40
|
|
|
|
|
|
1.78
|
|
|
(a)
|
Share based payment
charge including employer payroll taxes of €10.4 million and
non-operating M&A related costs of €1.3 million.
|
(b)
|
Exceptional items which
management believes will only recur over a limited number of
financial periods based in most cases on the completion of the
particular project or program, and do not have a continuing impact.
See table 'Adjusted EBITDA (unaudited) twelve months ended December
31, 2024' on the next page for a detailed list of exceptional
items.
|
(c)
|
Elimination of €14.4
million of net gains on repricing of debt, a €5.7 million gain from
the reversal of an impairment loss on a short-term investment,
€20.6 million of foreign exchange translation losses and €0.4
million of losses on derivatives.
|
(d)
|
Tax impact of the above
at the applicable tax rate for each adjustment, determined by the
nature of the item and the jurisdiction in which it
arises.
|
Nomad Foods Limited
Reconciliation of Non-IFRS
Financial Measures (continued)
The following table reconciles Adjusted EBITDA for the twelve
months ended December 31, 2024 to the reported results of
Nomad Foods for such period:
Adjusted EBITDA
(unaudited)
Twelve months ended
December 31, 2024
|
|
€ in
millions
|
For the twelve
months ended
December 31, 2024
|
|
|
Profit for the
period
|
227.1
|
|
|
Taxation
|
50.8
|
|
|
Net financing
costs
|
109.1
|
|
|
Depreciation and
amortization
|
96.9
|
|
|
Exceptional
items:
|
|
|
|
Business
Transformation Program
|
68.0
|
|
(a)
|
Settlement of
legacy matters
|
1.5
|
|
(b)
|
Other
Adjustments:
|
|
|
|
Other
add-backs
|
11.7
|
|
(c)
|
Adjusted EBITDA
(d)
|
565.1
|
|
|
|
|
(a)
|
Expenses associated
with the multi-year, enterprise-wide transformation and
optimization program which began in 2020. Expenses in the period
consist of restructuring, severance and transformational project
costs, including business technology transformation initiative
costs and related professional fees.
|
(b)
|
Income and expenses
associated with the release of acquired provisions relating to
periods prior to acquisition by the Company and other gains or
charges associated with items that were originally recognized as
exceptional.
|
(c)
|
Represents the
elimination of share based payment charge including employer
payroll taxes of €10.4 million and elimination of non-operating
M&A related costs of €1.3 million.
|
(d)
|
Adjusted EBITDA margin
of 18.2% for the twelve months ended December 31, 2024 is
calculated by dividing Adjusted EBITDA by Revenue of €3,099.8
million.
|
Nomad Foods Limited
Reconciliation of Non-IFRS
Financial Measures (continued)
The following table reconciles Adjusted financial information
for the twelve months ended December 31, 2023 to the reported
results of Nomad Foods for such period.
Adjusted Statements
of Profit or Loss (unaudited)
Twelve months ended
December 31, 2023
|
|
€ in
millions, except per share data
|
As reported for
the
twelve months ended
December 31, 2023
|
|
Adjustments
|
|
|
|
As adjusted for
the
twelve months ended
December 31, 2023
|
Revenue
|
3,044.5
|
|
—
|
|
|
|
3,044.5
|
Cost of
sales
|
(2,185.8)
|
|
—
|
|
|
|
(2,185.8)
|
Gross
profit
|
858.7
|
|
—
|
|
|
|
858.7
|
Other operating
expenses
|
(445.8)
|
|
27.1
|
|
(a)
|
|
(418.7)
|
Exceptional
items
|
(72.5)
|
|
72.5
|
|
(b)
|
|
—
|
Operating
profit
|
340.4
|
|
99.6
|
|
|
|
440.0
|
Finance
income
|
22.8
|
|
(17.0)
|
|
|
|
5.8
|
Finance
costs
|
(109.6)
|
|
7.5
|
|
|
|
(102.1)
|
Net financing
costs
|
(86.8)
|
|
(9.5)
|
|
(c)
|
|
(96.3)
|
Profit before
tax
|
253.6
|
|
90.1
|
|
|
|
343.7
|
Taxation
|
(60.9)
|
|
(8.0)
|
|
(d)
|
|
(68.9)
|
Profit for the
period
|
192.7
|
|
82.1
|
|
|
|
274.8
|
|
|
|
|
|
|
|
|
Weighted average shares
outstanding in millions - basic
|
170.6
|
|
—
|
|
|
|
170.6
|
Basic earnings per
share in €
|
1.13
|
|
|
|
|
|
1.61
|
Weighted average shares
outstanding in millions - diluted
|
171.2
|
|
—
|
|
|
|
171.2
|
Diluted earnings per
share in €
|
1.13
|
|
|
|
|
|
1.61
|
|
|
(a)
|
Share based payment
charge including employer payroll taxes of €26.1 million and
non-operating M&A related costs of €1.0 million.
|
(b)
|
Exceptional items which
management believes will only recur over a limited number of
financial periods based in most cases on the completion of the
particular project or program, and do not have a continuing impact.
See table 'Adjusted EBITDA (unaudited) twelve months ended December
31, 2023' on the next page for a detailed list of exceptional
items.
|
(c)
|
Elimination of €16.7
million of net gains on repricing of debt, €3.5 million of interest
cost on tax relating to legacy tax audits, €3.0 million of foreign
exchange translation losses, €1.0 million of losses on derivatives
and a €0.3 million gain from the reversal of an impairment loss on
a short-term investment.
|
(d)
|
Tax impact of the above
at the applicable tax rate for each adjustment, determined by the
nature of the item and the jurisdiction in which it
arises.
|
Nomad Foods Limited
Reconciliation of Non-IFRS
Financial Measures (continued)
The following table reconciles Adjusted EBITDA for the twelve
months ended December 31, 2023 to the reported results of
Nomad Foods for such period:
Adjusted EBITDA
(unaudited)
Twelve months
ended December 31, 2023
|
|
€ in
millions
|
For the twelve
months ended
December 31, 2023
|
|
|
Profit for the
period
|
192.7
|
|
|
Taxation
|
60.9
|
|
|
Net financing
costs
|
86.8
|
|
|
Depreciation and
amortization
|
95.0
|
|
|
Exceptional
items:
|
|
|
|
Information
Technology Transformation program
|
0.6
|
|
(a)
|
Business
Transformation Program
|
68.4
|
|
(b)
|
Fortenova
Group integration costs
|
4.3
|
|
(c)
|
Settlement of
legacy matters
|
(0.8)
|
|
(d)
|
Other
Adjustments:
|
|
|
|
Other
add-backs
|
27.1
|
|
(e)
|
Adjusted EBITDA
(f)
|
535.0
|
|
|
|
|
(a)
|
Expenses associated
with the Information Technology Transformation program, which are
primarily professional fees. The program was completed in
2023.
|
(b)
|
Expenses associated
with the multi-year, enterprise-wide transformation and
optimization program which began in 2020. Expenses in the period
consist of restructuring, severance and transformational project
costs, including business technology transformation initiative
costs and related professional fees.
|
(c)
|
Expenses associated
with the integration of the Fortenova Group acquired on September
30, 2021.
|
(d)
|
Income and expenses
associated with the release of acquired provisions relating to
periods prior to acquisition by the Company and other gains or
charges associated with items that were originally recognized as
exceptional.
|
(e)
|
Represents the
elimination of share based payment charge including employer
payroll taxes of €26.1 million and elimination of non-operating
M&A related costs of €1.0 million.
|
(f)
|
Adjusted EBITDA margin
of 17.6% for the twelve months ended December 31, 2023 is
calculated by dividing Adjusted EBITDA by Revenue of €3,044.5
million.
|
Nomad Foods Limited
Reconciliation of Non-IFRS
Financial Measures (continued)
Reconciliation from reported to organic revenue
growth/(decline)
The following table is a reconciliation of reported revenue
growth to Organic Revenue Growth for the three and twelve month
periods ended December 31, 2024.
Year on Year Growth
- December 31, 2024 compared with December 31,
2023:
|
|
|
Three months
ended
December 31, 2024
|
|
Twelve months
ended
December 31, 2024
|
|
|
|
YoY
change
|
|
YoY
change
|
|
|
Reported Revenue
Growth
|
4.3 %
|
|
1.8 %
|
|
|
|
|
|
|
|
|
Of which:
|
|
|
|
|
|
Organic Revenue
Growth/(Decline)
|
3.1 %
|
|
1.0 %
|
|
|
Translational FX
(a)
|
1.2 %
|
|
0.8 %
|
|
|
Total
|
4.3 %
|
|
1.8 %
|
|
|
|
|
(a)
|
Translational FX
is calculated by translating data of the current and comparative
periods using a budget foreign exchange rate that is set once a
year as part of the Company's internal annual forecast
process.
|
Nomad Foods Limited
Reconciliation of Non-IFRS
Financial Measures (continued)
Reconciliation from reported net cash flows from operating
activities to Adjusted free cash flow (unaudited)
The following table is a reconciliation of reported net cash
flows from operating activities to Adjusted free cash flow for the
twelve months ended December 31,
2024.
Twelve months ended
December 31, 2024
|
|
€ in
millions
|
Twelve months
ended
December 31, 2024
|
Net cash flows from
operating activities
|
435.4
|
Add back:
|
|
Cash flows relating to
exceptional items (a)
|
67.7
|
Employer taxes related
to share based payments (b)
|
1.6
|
Non-operating M&A
costs (c)
|
1.2
|
Deduct:
|
|
Capital expenditure
(d)
|
(80.3)
|
Net interest
paid
|
(102.0)
|
Payment of lease
liabilities (e)
|
(31.3)
|
Adjusted free cash
flow
|
292.3
|
|
|
Adjusted profit for
the period
|
288.8
|
Adjusted free cash
flow as % adjusted profit for the period
|
101 %
|
|
|
(a)
|
Adjustment to add back
cash flows related to exceptional items which are not considered to
be indicative of our ongoing operating cash flows.
|
(b)
|
Adjustment to add back
working capital movements related to employer taxes related to
share based payments which are not considered to be indicative of
our ongoing operating cash flows.
|
(c)
|
Adjustment to add back
cash flows related to non-operating M&A costs which are not
considered to be indicative of our ongoing operating cash
flows.
|
(d)
|
Defined as the sum of
property, plant and equipment and intangible assets purchased in
the year, which are considered part of the underlying business cash
flows.
|
(e)
|
These lease liabilities
are included in Net Cash Flows from Financing Activities. We
believe these payments are part of the underlying business cash
flows and should be reflected in Adjusted free cash
flow.
|
Forward-Looking Statements
Forward-Looking Statements
and Disclaimers
Certain statements in this announcement are forward-looking
statements which are based on the Company's expectations,
intentions and projections regarding its future performance,
anticipated events or trends and other matters that are not
historical facts, including the Company's expectations regarding
(i) its future operating and financial performance, including its
2025 guidance with respect to organic revenue growth, Adjusted
EBITDA growth, adjusted free cash flow conversion, Adjusted EPS,
and Adjusted EPS growth for 2025; (ii) its ability to generate
strong top and bottom-line growth and superior shareholder returns;
(iii) its cash generation, growth and success in 2025 and beyond;
(iv) its ability to outperform its industry peers; and (v) its
ability to deliver ten consecutive years of sales and Adjusted
EBITDA growth.
These statements are not guarantees of future performance and
are subject to known and unknown risks, uncertainties and other
factors that could cause actual results to differ materially from
those expressed or implied by such forward-looking statements,
including: (i) the Company's ability to effectively mitigate
factors that negatively impact its supply of raw materials,
including the conflict in Ukraine
and climate-related factors beyond the Company's control; (ii) the
Company's ability to successfully mitigate inflationary changes in
the market; (iii) the Company's ability to successfully identify
suitable acquisition targets and adequately evaluate the potential
performance of such acquisition targets; (iv) the Company's ability
to successfully implement its strategies (including its M&A
strategy) and strategic initiatives and to recognize the
anticipated benefits of such strategic initiatives; (v) innovations
introduced to the markets and the Company's ability to accurately
forecast the brands' performance; (vi) the Company's ability to
effectively compete in its markets; (vii) changes in consumer
preferences, such as meat substitutes, and the Company's failure to
anticipate and respond to such changes or to successfully develop
and renovate products; (viii) the effects of reputational damage
from unsafe or poor quality food products; (ix) the risk that
securities markets will react negatively to actions by the Company;
(x) the adequacy of the Company's cash resources to achieve its
anticipated growth agenda; (xi) increases in operating costs,
including labor costs, and the Company's ability to manage its cost
structure; (xii) fluctuations in the availability of food
ingredients and packaging materials that the Company uses in its
products; (xiii) the Company's ability to protect its brand names
and trademarks; (xiv) the Company's ability to prevent, or
remediate, any future cybersecurity incidents; (xv) loss of the
Company's financial arrangements with respect to receivables
factoring; (xvi) the loss of any of the Company's major customers
or a decrease in demand for its products; (xvii) economic
conditions that may affect the Company's future performance
including exchange rate fluctuations; (xviii) the Company's ability
to successfully interpret and respond to key industry trends and to
realize the expected benefits of its responsive actions; (xix) the
Company's failure to comply with, and liabilities related to,
environmental, health and safety laws and regulations; (xx) changes
in applicable laws or regulations; (xxi) the Company's ability to
remediate any material weaknesses in its internal control over
financial reporting; and (xxii) the other risks and uncertainties
disclosed in the Company's public filings and any other public
disclosures by the Company. Given these risks and uncertainties,
prospective investors are cautioned not to place undue reliance on
forward-looking statements. Forward-looking statements speak only
as of the date of such statements and, except as required by
applicable law, the Company does not undertake any obligation to
update or revise publicly any forward-looking statements, whether
as a result of new information, future events or otherwise.
No Offer or Solicitation
This release and referenced conference call is provided for
informational purposes only and does not constitute an offer to
sell, or an invitation to subscribe for, purchase or exchange, any
securities or the solicitation of any vote or approval in any
jurisdiction, nor shall there be any sale, issuance, exchange or
transfer of the securities referred to in this press release in any
jurisdiction in contravention of applicable law.
The release, publication or distribution of this announcement in
certain jurisdictions may be restricted by law and therefore
persons in such jurisdictions into which this announcement is
released, published or distributed should inform themselves about
and observe such restrictions.
View original
content:https://www.prnewswire.com/news-releases/nomad-foods-reports-fourth-quarter-and-full-year-2024-financial-results-and-raises-full-year-2025-earnings-outlook-302389539.html
SOURCE Nomad Foods Limited